The publication, titled "Effectiveness of homologous and heterologous boosters after primary schemes with Sputnik V, Astra-Zeneca and Sinopharm during the Ómicron period in adults over 50 years of age in Argentina", reviews the study carried out on the registry of 422,144 people who were tested in the province of Buenos Aires during the outbreak of the Ómicron variant.